Phase Holographic Imaging
@PhaseHolo
At PHI, we empower any lab to work cell-friendly by providing the next generation of innovative tools for non-invasive imaging and analysis of cells.
183 Following 532 Followers 388 Posts
Latest posts 5
PHI is currently conducting a fully guaranteed rights issue of ca. SEK 64 million. @BioStock_SWE contacted CEO Anders Månsson to learn more:
biostock.se/2024/12/phis-v…
biostock.se/2024/12/phis-v…
Latest @BioStock_SWE interview with our new CEO Anders Månsson and Chairman of the Board Goran Dubravcic!
youtu.be/XimVyVel7Fg?si…
youtu.be/XimVyVel7Fg?si…
www.youtube.com "We show increasing sales but there is still a lot of untapped potential”, says new CEO of PHI PHI specializes in non-invasive cell analysis, enabling researchers... We’re thrilled to #welcome Anders Månsson as PHI’s new CEO! 🚀
“I am very happy to have joined PHI. Together, we will drive new standards in #cellmonitoring and support advancements in cell-based therapies for the benefit of patients around the world.”
“I am very happy to have joined PHI. Together, we will drive new standards in #cellmonitoring and support advancements in cell-based therapies for the benefit of patients around the world.”
🎙️
In a new episode of our #OTCQB podcast, Phase Holographic Imaging (OTCQB: $PHIXF) CEO, Patrik Eschricht, discusses PHI's competitive advantages. PHI is a medical technology company that develops & markets its non-invasive time-lapse imaging instruments.
bit.ly/4dqZp43View quoted post on X
